Search research articles
Contact Us
Filters
Showing results (341-350 of 345) with videos related to
Page
of 35
Sort By:
You have reached the last page of results.
This site can display upto 345 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 19, 2021
Preface: promoting research in PLS: current knowledge and future challenges
Hiroshi Mitsumoto, Martin R Turner, , et al.
JAMA
|
April 5, 2022
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
JAMA Neurology
|
February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
James F Howard, Richard J Nowak, Gil I Wolfe, et al.
JAMA Neurology
|
March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials
Merit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Muscle & Nerve
|
December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine
Ted M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Page
of 35
Search research articles
Search
Showing results (341-350 of 345) with videos related to
Sort By:
Page
of 35
You have reached the last page of results.
This site can display upto 345 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 19, 2021
Preface: promoting research in PLS: current knowledge and future challenges
Hiroshi Mitsumoto, Martin R Turner, , et al.
JAMA
|
April 5, 2022
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
JAMA Neurology
|
February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
James F Howard, Richard J Nowak, Gil I Wolfe, et al.
JAMA Neurology
|
March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials
Merit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Muscle & Nerve
|
December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine
Ted M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Page
of 35